Clinical Trials

Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 10 of 126 Clinical Trials Related to Cancer

BMS CA224-098 Melanoma study

CA224-098: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy With Relatlimab and Nivolumab Fixed-dose Combination Versus Nivolumab Monotherapy After Complete Resection of Stage III-IV Melanoma

...
Doctor(s) Running This Study
Suresh G. Nair, MD

EA2174 GI Junction

A Phase II/III Study of Peri-operative Nivolumab and Ipilimumab in Patients with Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

...
Doctor(s) Running This Study
Maged F. Khalil, MD

NRG-HN005

A RANDOMIZED PHASE II/III TRIAL OF DE-INTENSIFIED RADIATION THERAPY FOR PATIENTS WITH EARLY-STAGE, P16-POSITIVE, NON-SMOKING ASSOCIATED OROPHARYNGEAL CANCER

...
Doctor(s) Running This Study
Maged F. Khalil, MD

MSK 21-183 Breast Cancer

Selective Use of ALND in cT1-2N1 HR+/HER2- Breast Cancer Patients with 1 or 2 Positive Sentinel Lymph Nodes Undergoing Upfront Surgery and Adjuvant Radiation: A Prospective Study

...
Doctor(s) Running This Study
Heiwon Chung Whang, MD

NRG-BN011

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

...
Doctor(s) Running This Study
Maged F. Khalil, MD

Mirati-EAP-001

Expanded Access of Adagrasib (MRTX849) in Patients with Advanced Solid Tumors Who Have a KRAS G12C Mutation

...
Doctor(s) Running This Study
Suresh G. Nair, MD

Mirati-EAP-001

Expanded Access of Adagrasib (MRTX849) in Patients with Advanced Solid Tumors Who Have a KRAS G12C Mutation

...
Doctor(s) Running This Study
Suresh G. Nair, MD

A031704 Renal Cell Cancer

PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]

...
Doctor(s) Running This Study
Maged F. Khalil, MD

Strata STR-005-001 Genomic Study

A Prospective Study Evaluating Combined Comprehensive Genomic And Transcriptomic Profiling With ctDNA Testing For Recurrence Detection And Treatment Monitoring Of Patients With Solid Tumors

...
Doctor(s) Running This Study
Suresh G. Nair, MD